---
figid: PMC9502403__marinedrugs-20-00570-g002
pmcid: PMC9502403
image_filename: marinedrugs-20-00570-g002.jpg
figure_link: /pmc/articles/PMC9502403/figure/marinedrugs-20-00570-f002/
number: Figure 2
figure_title: ''
caption: Saq B1 dose- and time-dependently inhibited the proliferation of SW480 and
  SW620 cells. Cells were treated with various concentrations of Saq B1 (0 to 0.5
  μmol/L) from 24 h to 72 h.
article_title: Saquayamycin B1 Suppresses Proliferation, Invasion, and Migration by
  Inhibiting PI3K/AKT Signaling Pathway in Human Colorectal Cancer Cells.
citation: Jianjiang Li, et al. Mar Drugs. 2022 Sep;20(9):570.
year: '2022'

doi: 10.3390/md20090570
journal_title: Marine Drugs
journal_nlm_ta: Mar Drugs
publisher_name: MDPI

keywords:
- saquayamycin B1
- colorectal cancer
- PI3K/AKT
- EMT
- apoptosis
- structure–activity relationship

---
